首页> 外文期刊>Oncology Research >Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors.
【24h】

Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors.

机译:腺苷通过腺苷受体调节人乳腺癌细胞中的细胞生长。

获取原文
获取原文并翻译 | 示例
           

摘要

Adenosine modulates the proliferation, survival, and apoptosis of many different cell types. The present study was performed to investigate the role of adenosine receptors in the human breast cancer cell lines MCF-7 and MDA-MB468. The biological effects of adenosine on the cells were analyzed by adenylyl cyclase and cell viability assay as well as RT-PCR of adenosine receptors. RT-PCR results show the expression of the transcript of all adenosine receptors in both cell lines. By using adenosine and selective adenosine receptor agonists or antagonists, we found that A3 stimulation reduced cell viability, which was abolished by pretreatment with A3 receptor antagonist. Moreover, we demonstrated that adenosine (natural agonist) triggers a cytotoxic signal via A3 receptor activation that was not seen for other subclasses of adenosine receptors. Intracellular cAMP concentration was changed significantly only for A3 and A2B receptor-selective agonists, which indicates the functional form of these receptors on the cell surface. In conclusion, our findings revealed the role of adenosine receptors in breast cancer cell lines on growth modulation role of A3 and functional form of A2B, although its involvement in cell growth modulation was not seen. Theses findings as well as data by others may provide a possible application of adenosine receptor agonists/antagonists in breast malignancies.
机译:腺苷调节许多不同细胞类型的增殖,存活和凋亡。进行本研究以研究腺苷受体在人乳腺癌细胞MCF-7和MDA-MB468中的作用。通过腺苷酸环化酶和细胞活力测定以及腺苷受体的RT-PCR来分析腺苷对细胞的生物学作用。 RT-PCR结果显示了两种细胞系中所有腺苷受体的转录本的表达。通过使用腺苷和选择性腺苷受体激动剂或拮抗剂,我们发现A3刺激降低了细胞活力,而A3受体拮抗剂预处理则消除了这种活力。此外,我们证明了腺苷(天然激动剂)会通过A3受体激活来触发细胞毒性信号,而腺苷受体的其他亚类则未见此信号。胞内cAMP浓度仅对A3和A2B受体选择性激动剂有显着变化,这表明这些受体在细胞表面的功能形式。总之,我们的发现揭示了腺癌细胞受体在乳腺癌细胞系中对A3的生长调节作用和A2B的功能形式的作用,尽管未见其参与细胞生长调节。这些发现以及其他人的数据可能提供腺苷受体激动剂/拮抗剂在乳腺恶性肿瘤中的可能应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号